Back to List View Graph View

Inflammation

Inflammation is a coordinated biological process involving immune activation and changes in affected tissues in response to infection, injury, metabolic disturbance, or other cellular stress.

Rebuilt from PubMed 18 Sept 2026 · no new papers today

Where the papers sit

13 papers study inflammation directly. Those 13 do not group into themes. Gastric injury, cancer prognosis, heart failure, metabolic liver disease, obesity, pain and thyroid eye disease share only inflammation-related endpoints; no single biological question or research direction unites them. They are no more alike than papers drawn from anywhere in the corpus. 1 new direction follows.

NEW DIRECTION

Inflammation is presented as a regulator of reproductive steroidogenesis through neuroendocrine–immune crosstalk

Neurotensin-mediated modulation of CYP19A1 and estrogen homeostasis during inflammation treats inflammation not merely as a pathological process, biomarker, or therapeutic target, but as a state that links immune activation to reproductive endocrine function: LPS-induced inflammation suppressed CYP19A1 and estrogen production, whereas NTSR1 activation reversed this effect in the brain, ovary, and plasma 42320252Jun. This extends the role assigned to inflammation in the set to include disruption of estrogen homeostasis and steroidogenic signaling.

Recent Findings on inflammation

Cross-Disease Inflammatory Research: METC, QWGDQ, compound 27, digoxin, and nintedanib reduced inflammatory or fibrotic injury in rat, mouse, and cellular models 42748059Sep42610928Aug42308786Jun42497831Jul42264059Jun. These effects involved oxidative stress, NF-κB, STAT3, TLR4, HIF-1α, GSDME-mediated pyroptosis, and proinflammatory cytokines, including IL-6 and TNF-α 42748059Sep42308786Jun42497831Jul42264059Jun. In gastric cancer, higher peripheral inflammation scores accompanied unfavorable clinicopathological features and poorer overall survival, while HBOT reduced serum CRP, IL-6, and TNF-α alongside depressive symptoms after stroke 42736302Sep42336256Jun. LS-MRE improved noninvasive identification of at-risk MASH and expanded recognition of patients eligible for pharmacotherapy 42579768Aug. The tVNS and PBMT-sMF protocols are testing whether inflammation-modulating interventions improve obesity-related metaflammation, mood, motivation, or chronic knee pain, so their clinical efficacy remains unresolved 42552546Aug42552011Aug. Heart failure, endocrine, and dermatology reviews increasingly place inflammation within immune, metabolic, mitochondrial, oxidative-stress, and aging pathways, supporting biomarker-guided and personalized interventions 42679357Sep42320252Jun41926038Apr.